Keyphrases
Treatment Validation
100%
Clinical Trials
100%
Childhood Autism
100%
Autism
100%
Docosahexaenoic Acid
80%
Gene Variants
40%
Therapeutic Trial
40%
Genotype
30%
Isoprostanes
20%
Global Severity
20%
Clinical Applicability
20%
Lipid Biomarkers
20%
Clinical Benefit
20%
New Therapies
20%
Oxidative Stress
20%
Urinary Excretion
20%
Acid Metabolism
10%
Oxidative Stress Markers
10%
Clinical Change
10%
Change of Measure
10%
Acid Treatment
10%
Functional Aspects
10%
Potential Clinical Applications
10%
Clinical Risk
10%
Placebo Treatment
10%
Omega-3 Fatty Acids
10%
Placebo-controlled
10%
Response Monitoring
10%
Urinary Biomarkers
10%
Behavioral Symptoms
10%
Evidence Support
10%
Behavioral Aspects
10%
Clinical Treatment
10%
Autism Severity
10%
GSTM1
10%
Functional Capacity
10%
Patient's Will
10%
Autistic Disorder
10%
Response to Therapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Docosahexaenoic Acid
100%
Biological Marker
62%
Combination Therapy
50%
Isoprostane Derivative
25%
Placebo
25%
Autism
12%
Omega-3 Fatty Acid
12%
Neuroscience
Autism
100%
Docosahexaenoic Acid
47%
Oxidative Stress
17%
Placebo
11%
Isoprostane
11%
Pervasive Developmental Disorder
5%
Metabolic Pathway
5%
Omega 3 Fatty Acid
5%